期刊文献+

转染结缔组织生长因子基因的大鼠肾系膜细胞纤连蛋白和Ⅳ型胶原表达的改变 被引量:3

Changes of fibronectin and type Ⅳ collagen expression in cultured rat mesangial cells transfected with connective tissue growth factor expression vector
原文传递
导出
摘要 目的观察大鼠肾系膜细胞(MsC)转染结缔组织生长因子(CTGF)基因转染阳性细胞克隆中纤连蛋白(FN)和Ⅳ型胶原(Col Ⅳ)表达的改变,探讨 CTGF 在肾小球硬化发生中的作用。方法经脂质体介导将含有 CTGF 的重组表达质粒转染至大鼠 MsC,用 G418筛选及 Western blot 和半定量逆转录聚合酶链反应作鉴定;检测阳性克隆 FN、Col Ⅳ蛋白及其 mRNA 表达的改变。结果成功建立高表达 CTGF 的阳性 MsC 克隆(MCT-1,2),并证实其与对照组相比,阳性 MsC 克隆 FN、Col Ⅳ的表达均有上调,其 FN 蛋白及其 mRNA 表达分别增高2.9倍和3.2倍,Col Ⅳ蛋白和 mRNA 表达分别增高为2.4倍和3.8倍。结论 CTGF 可促进 MsC 的 FN、Col Ⅳ的表达,表明其在肾小球硬化发生中起促进作用。 Objective To study the role of connective tissue growth factor (CTGF) in the development of glomerulosclerosis by experimental alteration of fibronectin (FN) and Type Ⅳ collagen ( Col Ⅳ) expression in cultured rat mesangial cells (MsC). Methods CTGF expression vector was transfected into MsC by Lipofectimine method. Protein and mRNA expression levels of CTGF, FN and Col Ⅳ were studied by Western blot and reverse transcription-polymerase chain reaction (RT-PCR) respectively. Results Two of MsC clones ( MCT-1 and MCT-2) with CTGF overexpression were successfully established and found to have significant increases of FN and Col Ⅳ at both protein and mRNA levels. Compared with the controls, the expression of FN protein and mRNA in the two clones were 3.2 times ( P 〈 0.05 ) and 2.9 times ( P 〈 0. 05 ) higher respectively. The expression of Col 1V protein and mRNA was 3.8 times ( P 〈 0. 01 ) and 2. 4 times ( P 〈 0. 01 ) higher respectively. Conclusion CTGF up-regulates FN and Col Ⅳ expression in MsC and may play an important role in the development of glomerulosclerosis.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2006年第9期555-558,共4页 Chinese Journal of Pathology
基金 国家自然科学基金(30570859)
关键词 肾小球硬化症 病灶性 转染 纤连蛋白类 胶原 Glomerulosclerosis,focal Transfection Fibronectin Collagen
  • 相关文献

参考文献14

  • 1Bradham DM,Igarashi A,Potter RL,et al.Connective tissue growth factor:a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.J Cell Biol,1991,114:1285-1294.
  • 2Grotendorst GR,Okochi H,Hayashi N.A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene.Cell Growth Differ,1996,7:469-480.
  • 3Fraizier K,Williams S,Kothapalli D,et al.Stimulation of fibroblast cell growth,matrix production,and granulation tissue formation by connective tissue growth factor.J Invest Dematol,1996,107:404-411.
  • 4Muphy M,Godson C,Cannon S,et al.Suppression substactive hybridization identifies high glucose leves as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cell.J Biol Chem,1999,274:5830-5834.
  • 5于鸿,王小刚,汪怡,陈琦,张秀荣,郭慕依.转染Smad 7基因的大鼠肾系膜细胞基质金属蛋白酶2及其组织抑制因子2表达的改变[J].中华病理学杂志,2003,32(6):544-547. 被引量:44
  • 6Klahr S,Morrissey JJ.The role of vascoactive compounds,growth factors and cytokines in the progression of renal disease.Kidney Int (suppl),2000,75:S7-S14.
  • 7Oemar BS,Werner A,Garnier JM,et al.Human connective tissue growth factor is expressed in advanced atherosclerosis lesions.Circulation,1997,95:831-839.
  • 8Twigg SM,Joly AH,Chen MM,et al.Connective tissue growth factor/ IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts.Endocrinology,2002,143:1260-1269.
  • 9Qi W,Twigg S,Chen X,et al.Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis.Am J Physiol Renal Physiol,2005,288:F800-809.
  • 10Yokoi H,Mukoyama M,Nagae T,et al.Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis.J Am Soc Nephrol,2004,15:1430-1440.

二级参考文献19

  • 1于鸿,汪怡,王小刚,许杰,赵仲华,张秀荣,郭慕依.转染Smad2基因的大鼠肾系膜细胞Ⅰ、Ⅲ型胶原表达的改变[J].复旦学报(医学版),2004,31(5):538-539. 被引量:1
  • 2张明,郭慕依,陈琦,金惠铭.大鼠肾小球系膜细胞培养[J].上海医科大学学报,1995,22(3):207-209. 被引量:11
  • 3Poncelet AC,de Caestecker MP,Schnaper HW. The transforming gowth factor-beta /SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int,1999,56:1354-1365.
  • 4Moustakas A,Souchelnytskyi S,Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci,2001,114(Pt 24):4359-4369.
  • 5Poucelet AC,Schnaper HW. Regulation of human mesangial cell collagen expression by transforming growth factor beta 1. Am J Physiol,1998,275(3 Pt 2):F458-F466.
  • 6Boider WA,Nobel NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int,1997,51:1388-1396.
  • 7Massague J,Watton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J,2000,19:1745-1754.
  • 8Verrecchia F,Chu ML,Mauviel A. Indentification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem,2001,276:17058-17062.
  • 9Piek E,Ju WJ,Heyer J,et al. Functional characterization of transforming growth factor beta signaling in Smad 2- and Smad3-deficient fibroblasts. J Biol Chem,2001,276:19945-19953.
  • 10Li JH,Zhu HJ,Huang XR,et al. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad 2 activation. J Am Soc Nephrol,2002,13:1464-1472.

共引文献46

同被引文献44

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部